Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em Neurociências. / Made available in DSpace on 2012-10-23T03:32:10Z (GMT). No. of bitstreams: 1
243258.pdf: 1269501 bytes, checksum: f303d1819c487d037bf1be8c850acd98 (MD5) / Schinus molle L. (Anacardiaceae), among other uses, is popularly employed for the treatment of depression. In this study, the antidepressant-like effect of the ethanolic and hexanic extracts from leaves of Schinus molle was investigated in the mouse tail suspension test (TST) and/or in the forced swimming test (FST), two predictive models of depression. The ethanolic extract (600-1000 mg/kg, p.o.) significantly reduced the immobility time in the TST, but not in the FST, and produced a reduction in the locomotor activity in the open-field test (OF).The immobility time in the TST was significantly reduced by the hexanic extract (dose range 30-600 mg/kg, p.o.), without accompanying changes in ambulation when assessed in an open-field test. The efficacy of this extract was found to be comparable to that of fluoxetine (10 mg/kg, p.o.). The anti-immobility effect of the hexanic extract (100 mg/kg, p.o.) was prevented by pretreatment of mice with -chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for four consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT1A receptor antagonist), WAY100635 (0.1 mg/kg, s.c., a selective 5-HT1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT2A/2C receptor antagonist), MDL72222 (0.1 mg/kg, i.p., a 5-HT3 receptor antagonist), prazosin (1 mg/kg, i.p., an á1-adrenoceptor antagonist), yohimbine (1 mg/kg, i.p., an á2-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a D1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a D2 receptor antagonist). Rutin (1 mg/kg, p.o.) isolated from the ethanolic extract and the fraction I (6-17; fatty acid esthers), isolated from the hexanic extract significantly reduced the immobility time in the TST, without altering the locomotor activity in the open-field test. However, the fractions II (33-34; composed by a mixture of fatty alcohols) and III (43-45; mixture of triterpenes), isolated from the hexanic extract did not cause changes in the immobility time in the TST. It may be concluded that the hexanic extract of Schinus molle produces an antidepressant-like effect that seems to be dependent on its interaction with the serotonergic, noradrenergic and dopaminergic systems. These results provide evidence that the hexanic extract from S. molle shares with established antidepressants some pharmacological effects, at least at a preclinical level. Moreover, the fatty acid esthers (fraction 6-17) may be responsible for the antidepressant-like action of this extract in the TST. The ethanolic extract of Schinus molle significantly reduced the immobility time in the TST. Rutin, isolated from this extract, may be also responsible for the antidepressant-like action.
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.ufsc.br:123456789/89866 |
| Date | January 2007 |
| Creators | Machado, Daniele Guilhermano |
| Contributors | Universidade Federal de Santa Catarina, Rodrigues, Ana Lucia Severo |
| Publisher | Florianópolis, SC |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Format | 1 v.| il., grafs. |
| Source | reponame:Repositório Institucional da UFSC, instname:Universidade Federal de Santa Catarina, instacron:UFSC |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0021 seconds